PfTBV-Consortuim

Assessing safety, efficacy and transmission blocking properties of the new anti-malarial KAF156 combined with a new formulation of lumefantrine in children and adults with uncomplicated Plasmodium sp. malaria in West and Central Africa (WANECAM II) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Abdoulaye Djimde | Gabon, Burkina Faso, Mali, Niger

Read more

Publications similaires

  • 2019 Jan – 2020 Dec

    Ex-vivo clinical candidate drug assay against field clinical isolated blood stages parasites of P. malariae and P. ovale using 10 compounds from MMV. Medicines for Malaria Venture (MMV), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Laurent Dembele | Ghana, Mali

  • PYRAPREG

    Malaria in pregnant is a public health problem in sub Saharan countries where 11 million pregnancies are exposed to malaria infection. Plasmodium falciparum in pregnant can cause adverse maternal health and poor birth outcomes. Artemisin-based Combination Therapy (ACT) used in treatment of uncomplicated Plasmodium falciparum malaria in pregnant women has the efficacy in Africa. The…

  • 2019 Oct – 2022 Oct | $703k

    Using single-cell RNAseq to investigate human malaria parasite transmission dynamics Medical Research Council (MRC), UK, Wellcome Trust Sanger Institute, UK, University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Mara K. N. Lawniczak, Abdoulaye Djimde | Africa, Central, Africa, Eastern, Africa, Southern, Mali, United Kingdom

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *